Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

The role of nuclear factor kappaB in pancreatic cancer and the clinical applications of targeted therapy.

Holcomb B, Yip-Schneider M, Schmidt CM.

Pancreas. 2008 Apr;36(3):225-35. doi: 10.1097/MPA.0b013e31815b3207. Review.

PMID:
18362834
2.

Nuclear factor-kappa B and cancer: its role in prevention and therapy.

Bharti AC, Aggarwal BB.

Biochem Pharmacol. 2002 Sep;64(5-6):883-8. Review.

PMID:
12213582
3.

NF-kappaB as a potential molecular target for cancer therapy.

Lee CH, Jeon YT, Kim SH, Song YS.

Biofactors. 2007;29(1):19-35. Review.

PMID:
17611291
4.

Targeting NF-kappaB signaling pathway suppresses tumor growth, angiogenesis, and metastasis of human esophageal cancer.

Li B, Li YY, Tsao SW, Cheung AL.

Mol Cancer Ther. 2009 Sep;8(9):2635-44. doi: 10.1158/1535-7163.MCT-09-0162.

5.

Nuclear factor-kappaB: the enemy within.

Aggarwal BB.

Cancer Cell. 2004 Sep;6(3):203-8. Review.

6.

Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs.

Nakanishi C, Toi M.

Nat Rev Cancer. 2005 Apr;5(4):297-309. Review.

PMID:
15803156
7.

Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck.

Allen CT, Ricker JL, Chen Z, Van Waes C.

Head Neck. 2007 Oct;29(10):959-71. Review.

PMID:
17405170
8.

Exploiting our knowledge of NF-kappaB signaling for the treatment of mammary cancer.

Haffner MC, Berlato C, Doppler W.

J Mammary Gland Biol Neoplasia. 2006 Jan;11(1):63-73. Review.

PMID:
16900390
9.

NF-kappaB in pancreatic cancer.

Sclabas GM, Fujioka S, Schmidt C, Evans DB, Chiao PJ.

Int J Gastrointest Cancer. 2003;33(1):15-26. Review.

PMID:
12909735
10.

NF-kappaB as a molecular target in adjuvant therapy of gastrointestinal carcinomas.

Yu YY, Li Q, Zhu ZG.

Eur J Surg Oncol. 2005 May;31(4):386-92. Review.

PMID:
15837045
11.

Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosis.

Wilson C, Purcell C, Seaton A, Oladipo O, Maxwell PJ, O'Sullivan JM, Wilson RH, Johnston PG, Waugh DJ.

J Pharmacol Exp Ther. 2008 Dec;327(3):746-59. doi: 10.1124/jpet.108.143826.

12.
13.

Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products.

Kunnumakkara AB, Diagaradjane P, Guha S, Deorukhkar A, Shentu S, Aggarwal BB, Krishnan S.

Clin Cancer Res. 2008 Apr 1;14(7):2128-36. doi: 10.1158/1078-0432.CCR-07-4722.

14.
15.

Nuclear factor-kappa B as a predictor of treatment response in breast cancer.

Garg AK, Hortobagyi GN, Aggarwal BB, Sahin AA, Buchholz TA.

Curr Opin Oncol. 2003 Nov;15(6):405-11. Review.

PMID:
14624221
16.

Targeting of nuclear factor-kappaB and proteasome by dithiocarbamate complexes with metals.

Cvek B, Dvorak Z.

Curr Pharm Des. 2007;13(30):3155-67. Review.

PMID:
17979756
17.

Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.

Pandey MK, Sung B, Kunnumakkara AB, Sethi G, Chaturvedi MM, Aggarwal BB.

Cancer Res. 2008 Jul 1;68(13):5370-9. doi: 10.1158/0008-5472.CAN-08-0511.

18.

Pretherapy nuclear factor-kappaB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma.

Izzo JG, Correa AM, Wu TT, Malhotra U, Chao CK, Luthra R, Ensor J, Dekovich A, Liao Z, Hittelman WN, Aggarwal BB, Ajani JA.

Mol Cancer Ther. 2006 Nov;5(11):2844-50.

19.

Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth.

Sakamoto K, Maeda S, Hikiba Y, Nakagawa H, Hayakawa Y, Shibata W, Yanai A, Ogura K, Omata M.

Clin Cancer Res. 2009 Apr 1;15(7):2248-58. doi: 10.1158/1078-0432.CCR-08-1383.

20.
Items per page

Supplemental Content

Support Center